GPX4 and cancer: For example, commonly used ferroptosis inducers such as ML-162 and RSL3 reduce GPX4 activity to induce the ferroptosis of cancer cells and have been applied in the treatment of advanced treatment-resistant prostate cancer, ccRCC, HCC, TNBC and other cancers171, 172, 173, 174.